IL2RA Genetic Heterogeneity in Multiple Sclerosis and Type 1 Diabetes Susceptibility and Soluble Interleukin-2 Receptor Production
Lisa M. Maier(Broad Institute), David A. Hafler(Yale University), Cristin Aubin(Broad Institute), Jason D. Cooper(University of Cambridge), Brian C. Healy(Evidence (Italy)), Philip L. De Jager(Broad Institute), Linda S. Wicker(Juvenile Diabetes Research Foundation), Neil Walker, Stephen Sawcer(University of Cambridge), Kate Downes(National Health Service), David E. Anderson(University of California, Davis), Jorge R. Oksenberg(University of California, San Francisco), Christopher E. Lowe(University of Cambridge), Pamela Clark(University of Cambridge), Stephen L. Hauser(University of California, San Francisco), John A. Todd(University of Oxford), Alistair Compston(University of Cambridge), Christopher Severson(Brigham and Women's Hospital)
Cited by 244
Related Papers
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
|Nature|2007|9.7k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k